Serotonin and Decision-Making: A Behavioral Study

We are investigating how serotonin influences learning and decision-making in individuals. The study also looks at how personal traits like perfectionism and impulsivity relate to these behaviors.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Escitalopram Sandoz
Escitalopram Sandoz is a medicine used to treat depression and certain anxiety disorders by improving mood and reducing excessive worry.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Escitalopram
Escitalopram is a substance that helps improve mood and reduce anxiety in people with depression or anxiety disorders.
Escitalopram Oxalate
Escitalopram oxalate is a substance that helps relieve depression and anxiety by increasing serotonin activity in the brain.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aciprex
Amasci
Apoescitaxin Oro

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Radboud Universiteit Nijmegen
Donders Institute for Brain, Cognition and Behaviour
Nijmegen, Netherlands
Sponsor: Radboud Universiteit Nijmegen
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.